rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population

Neuromolecular Med. 2017 Sep;19(2-3):293-299. doi: 10.1007/s12017-017-8444-z. Epub 2017 May 31.

Abstract

Alzheimer's (AD) and Parkinson's diseases (PD) share clinical and pathological features, suggesting that they could have common pathogenic mechanisms, as well as overlapping genetic modifiers. Here, we performed a case-control study in a Brazilian population to clarify whether the risk of AD and PD might be influenced by shared polymorphisms at PICALM (rs3851179), CR1 (rs6656401) and CLU (rs11136000) genes, which were previously identified as AD risk factors by genome-wide association studies. For this purpose, 174 late-onset AD patients, 166 PD patients and 176 matched controls were genotyped using TaqMan® assays. The results revealed that there were significant differences in genotype and allele frequencies for the SNP PICALM rs3851179 between AD/PD cases and controls, but none for CR1 rs6656401 and CLU rs11136000 intronic polymorphisms. After stratification by APOE ε4 status, the protective effect of the PICALM rs3851179 A allele in AD cases remains evident only in APOE ε4 (-) carriers, suggesting that the APOE ε4 risky allele weakens its protective effect in the APOE ε4 (+) subgroup. More genetic studies using large-sized and well-defined matched samples of AD and PD patients from mixed populations as well as functional correlation analysis are urgently needed to clarify the role of rs3851179 in the AD/PD risk. An understanding of the contribution of rs3851179 to the development of AD and PD could provide new targets for the development of novel therapies.

Keywords: Alzheimer’s disease; CLU; CR1; PICALM; Parkinson’s disease; Single nucleotide polymorphisms.

MeSH terms

  • Age of Onset
  • Aged
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics
  • Brazil
  • Case-Control Studies
  • Clusterin / genetics
  • Epistasis, Genetic
  • Female
  • Genetic Association Studies
  • Humans
  • Male
  • Middle Aged
  • Monomeric Clathrin Assembly Proteins / genetics*
  • Monomeric Clathrin Assembly Proteins / physiology
  • Parkinson Disease / genetics*
  • Polymorphism, Single Nucleotide*
  • Receptors, Complement 3b / genetics

Substances

  • Apolipoprotein E4
  • CLU protein, human
  • CR1 protein, human
  • Clusterin
  • Monomeric Clathrin Assembly Proteins
  • PICALM protein, human
  • Receptors, Complement 3b